(R) CHOSA Oncology AB – publicerar bokslutskommuniké för 2025.

Read more

Riktad emission i CHOSA Oncology AB registrerad på Bolagsverket

Read more

Precision Oncology patent application targeting Platinum Response and Immunotherapy Synergy

Read more

CHOSA - Patentansökan inom precisionsonkologi med fokus på platinarespons och synergier med immunterapi

Read more

(R) CHOSA Oncology AB resolves on a directed issue of units of initially approximately SEK 7.3 million

Read more

(R) CHOSA Oncology AB beslutar om riktad emission av units om initialt cirka 7,3 MSEK

Read more

(R) CHOSA - The market now doubles for Platin-DRP®, which predicts overall survival in lung cancer patients based on NanoString data

Read more

(R) CHOSA - Marknaden dubbleras nu för Platin-DRP® som förutsäger totalöverlevnad hos patienter med lungcancer genom NanoString-data

Read more

(R) CHOSA Oncology AB – Kvartalsrapport juli-sept 2025.

Read more

CHOSA - Platinum chemotherapy is the backbone of PD-1/PD-L1-based lung cancer therapy

Read more

CHOSA - Platinabaserad kemoterapi är ryggraden i PD-1/PD-L1-baserad lungcancerbehandling

Read more

CHOSA’s presented data on the carboplatin response predictor in breast cancer patients on the ESMO conference

Read more